Antibe Therapeutics Inc. Announces The Formation Of Its Clinical Advisory Board

Antibe Therapeutics Inc. Announces The Formation Of Its Clinical Advisory Board

Antibe Therapeutics Inc. ("Antibe" or the "Corporation") (TSXV:ATE) is pleased to announce the formation of its Clinical Advisory Board with the appointment of three distinguished, internationally recognized gastroenterologists. The three appointees are: Dr. Francis Chan, Professor of Medicine at The Chinese University of Hong Kong; Dr. Angel Lanas, Professor of Medicine, University of Zaragoza (Spain); and Dr. James Scheiman, Professor of Internal Medicine at the University of Michigan.